The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter 
Professionals >> Visit The Body PROThe Body en Espanol
Ask the Experts About

Choosing Your MedsChoosing Your Meds
Rollover images to visit our other forums!
  • Email Email
  • Glossary Glossary

Oct 2, 2009

I had live sex for 10 minutes with a lady who 12 hours later tested positive and i tested negative. That was our first tie. I was given tablets Trouimune to take. Dr said am at low risk because the WBC count was even high. True. Advise

Response from Dr. Young


Since you were given Triomune, I can assume that you don't live in the US or Europe.

Triomune (d4T/3TC/nevirapine) is a really bad idea for post-exposure prophylaxis. This is because in persons with normal immune systems (I assume, like you) have a much greater risk of very serious liver toxicity from nevirapine. Before we were mindful of this, many persons did get nevirapine for PEP, resulting in several cases of liver failure, even a few requiring liver failure. By the way, nevirapine is not recommended for HIV+ individuals if their CD4 count is greater than 250 (for women) or 400 (for men).

Either way, I'd recommend that you not continue with nevirapine, rather should be on (minimally) a two NRTI regimen such as d4T+3TC, AZT+3TC (Combivir) or tenofovir+FTC (Truvada). Any PEP treatment should be taken for 28 days.


Is this PEP regimen OK?
Is it side effect or weakness

  • Email Email
  • Glossary Glossary



This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint